Citation Impact
Citing Papers
Individuality in gut microbiota composition is a complex polygenic trait shaped by multiple environmental and host genetic factors
2010 Standout
Antiemetics: American Society of Clinical Oncology Clinical Practice Guideline Update
2011 Standout
Metabolomics analysis reveals large effects of gut microflora on mammalian blood metabolites
2009 Standout
Delivery mode shapes the acquisition and structure of the initial microbiota across multiple body habitats in newborns
2010 Standout
ASPP: a new family of oncogenes and tumour suppressor genes
2007
The metabolism of primary, 7-oxo, and 7 beta-hydroxy bile acids by Clostridium absonum.
1982
Separation of 7 alpha- and 7 beta-hydroxysteroid dehydrogenase activities from clostridium absonum ATCC# 27555 and cellular response of this organism to bile acid inducers.
1983
Developmental microbial ecology of the neonatal gastrointestinal tract
1999
Cell cycle‐dependent nuclear retention of p53 by E2F1 requires phosphorylation of p53 at Ser315
2005
Cancer nanomedicine: progress, challenges and opportunities
2016 Standout
Chemotherapy for small cell lung cancer
2003
Mesoporous silica nanoparticles in biomedical applications
2012 StandoutNobel
Steroid metabolism with intestinal microorganisms
1993
Signal Transduction by the JNK Group of MAP Kinases
2000 Standout
Clostridium scindens baiCD and baiH genes encode stereo-specific 7α/7β-hydroxy-3-oxo-Δ4-cholenoic acid oxidoreductases☆
2007
Precision microbiome reconstitution restores bile acid mediated resistance to Clostridium difficile
2014 StandoutNature
Obesity-induced gut microbial metabolite promotes liver cancer through senescence secretome
2013 StandoutNature
Prognostic factors for survival in advanced non-small-cell lung cancer: univariate and multivariate analyses including recursive partitioning and amalgamation algorithms in 1,052 patients. The European Lung Cancer Working Party.
1995
The Human Intestinal Microbiome in Health and Disease
2016 Standout
Phase II trial of irinotecan in patients with metastatic colorectal carcinoma.
1997
Telomeres and telomerase: A dual role in hepatocarcinogenesis
2004
Indigenous Bacteria from the Gut Microbiota Regulate Host Serotonin Biosynthesis
2015 Standout
Gut Microbiota Regulate Motor Deficits and Neuroinflammation in a Model of Parkinson’s Disease
2016 Standout
Blinded by the Light: The Growing Complexity of p53
2009 Standout
Nanoparticles functionalised with reversible molecular and supramolecular switches
2010 StandoutNobel
Bacterial biofilms: from the Natural environment to infectious diseases
2004 Standout
Oesophageal carcinoma
2013 Standout
Bile salt biotransformations by human intestinal bacteria
2005 Standout
Phase I clinical and pharmacokinetic study of irinotecan, fluorouracil, and leucovorin in patients with advanced solid tumors.
1996
Enterochromaffin Cells Are Gut Chemosensors that Couple to Sensory Neural Pathways
2017 StandoutNobel
Conversion of cholic acid and chenodeoxycholic acid into their 7-oxo derivatives byBacteroides intestinalisAM-1 isolated from human feces
2009
Detection of topoisomerase I gene point mutation in CPT-11 resistant lung cancer cell line
1992
Atezolizumab versus docetaxel for patients with previously treated non-small-cell lung cancer (POPLAR): a multicentre, open-label, phase 2 randomised controlled trial
2016 Standout
A biosynthetic pathway for a prominent class of microbiota-derived bile acids
2015
Diet rapidly and reproducibly alters the human gut microbiome
2013 StandoutNature
Mesoporous Silica Nanoparticles: Synthesis, Biocompatibility and Drug Delivery
2012 Standout
Physiology and Pathophysiology of Purinergic Neurotransmission
2007 Standout
A phase II study of weekly irinotecan as first-line therapy for patients with metastatic pancreatic cancer
2006
Topoisomerase I inhibitors: topotecan and irenotecan
1994
Mitochondrial Membrane Permeabilization in Cell Death
2007 Standout
A review of the pharmacology and clinical activity of new chemotherapy agents for the treatment of colorectal cancer
1999
Mesoporous Silica Nanoparticles as a Delivery System for Hydrophobic Anticancer Drugs
2007
Intestinal Crosstalk between Bile Acids and Microbiota and Its Impact on Host Metabolism
2016 Standout
Microtubules as a target for anticancer drugs
2004 Standout
Induction of cleavage in topoisomerase I c-DNA by topoisomerase I enzymes from calf thymus and wheat germ in the presence and absence of camptothecin
1993 StandoutNobel
Irinotecan plus Fluorouracil and Leucovorin for Metastatic Colorectal Cancer
2000 Standout
Lipid signalling couples translational surveillance to systemic detoxification in Caenorhabditis elegans
2015 StandoutNobel
5-Fluorouracil: mechanisms of action and clinical strategies
2003 Standout
Irinotecan combined with fluorouracil compared with fluorouracil alone as first-line treatment for metastatic colorectal cancer: a multicentre randomised trial
2000 Standout
Anticancer drug design based on plant-derived natural products
1999
Small-cell lung cancer
2005
Phase II study of CPT-11, a new camptothecin derivative, in metastatic colorectal cancer. CPT-11 Gastrointestinal Cancer Study Group.
1993
Phase II trial of CPT-11 in patients with advanced pancreatic cancer, an EORTC early clinical trials group study
1995
Poly (amino acid) micelle nanocarriers in preclinical and clinical studies
2008
Camptothecins: from bench research to hospital wards.
1994
Incomplete recovery and individualized responses of the human distal gut microbiota to repeated antibiotic perturbation
2010 Standout
Biochemical Modulation of Cisplatin Mechanisms of Action: Enhancement of Antitumor Activity and Circumvention of Drug Resistance
2003 Standout
Gut Microbiota in Health and Disease
2010 Standout
Novel SN-38–Incorporating Polymeric Micelles, NK012, Eradicate Vascular Endothelial Growth Factor–Secreting Bulky Tumors
2006
Controlled-Access Hollow Mechanized Silica Nanocontainers
2009 StandoutNobel
Adherence of Glucan-Positive and Glucan-Negative Streptococcal Strains to Normal and Damaged Heart Valves
1978
Close Is Not Enough
2000 StandoutNobel
Assignment of Eubacterium sp. VPI 12708 and related strains with high bile acid 7alpha-dehydroxylating activity to Clostridium scindens and proposal of Clostridium hylemonae sp. nov., isolated from human faeces.
2000
FOLFIRINOX versus Gemcitabine for Metastatic Pancreatic Cancer
2011 Standout
Irinotecan is an active agent in untreated patients with metastatic colorectal cancer.
1996
Chemotherapy of advanced non-small cell lung cancer
1999
Interaction of an alkylating camptothecin derivative with a DNA base at topoisomerase I-DNA cleavage sites.
1995 StandoutNobel
Lipopolymers, Isoprenoids, and the Assembly of the Gram-Positive Cell Wall
1984
Topoisomerase I Inhibitors: An Overview of the Camptothecin Analogs
1994
Clostridium hiranonis sp. nov., a human intestinal bacterium with bile acid 7alpha-dehydroxylating activity.
2001
pH Clock-Operated Mechanized Nanoparticles
2009 StandoutNobel
Hepatocellular Carcinoma: Epidemiology and Molecular Carcinogenesis
2007 Standout
Assessment of fecal bacteria with bile acid 7 alpha-dehydroxylating activity for the presence of bai-like genes
1997
Irinotecan in esophageal cancer.
2000
Enzyme-Responsive Snap-Top Covered Silica Nanocontainers
2008 StandoutNobel
Formation of ursodeoxycholic acid from chenodeoxycholic acid by a 7 beta-hydroxysteroid dehydrogenase-elaborating Eubacterium aerofaciens strain cocultured with 7 alpha-hydroxysteroid dehydrogenase-elaborating organisms
1982
High Glucose–Induced Apoptosis in Human Endothelial Cells Is Mediated by Sequential Activations of c-Jun NH 2 -Terminal Kinase and Caspase-3
2000
Light-Operated Mechanized Nanoparticles
2009 StandoutNobel
Host-Gut Microbiota Metabolic Interactions
2012 StandoutScience
Noninvasive Remote-Controlled Release of Drug Molecules in Vitro Using Magnetic Actuation of Mechanized Nanoparticles
2010 StandoutNobel
Magnetic Nanoparticles: Design and Characterization, Toxicity and Biocompatibility, Pharmaceutical and Biomedical Applications
2012 Standout
pH-Operated Nanopistons on the Surfaces of Mesoporous Silica Nanoparticles
2010 StandoutNobel
Microbiota transplantation restores normal fecal bile acid composition in recurrentClostridium difficileinfection
2013
Targeted Disruption of the Mouse Topoisomerase I Gene by Camptothecin Selection
1996 StandoutNobel
Phase I and pharmacokinetic trial of weekly CPT-11.
1993
Multiple event activation of a generic prodrug trigger by antibody catalysis
1999 StandoutNobel
Metabolism of β-muricholic acid in man
1985
Structural Basis of Type II Topoisomerase Inhibition by the Anticancer Drug Etoposide
2011 StandoutScience
Cellular pharmacology of the combination of the DNA topoisomerase I inhibitor SN-38 and the diaminocyclohexane platinum derivative oxaliplatin.
1999
Mechanized Silica Nanoparticles: A New Frontier in Theranostic Nanomedicine
2011 StandoutNobel
Physiology of Microglia
2011 Standout
Works of N Masuda being referenced
Phase I and pharmacologic study of irinotecan in combination with cisplatin for advanced lung cancer
1993
Randomised phase III trial of irinotecan combined with cisplatin for advanced non-small-cell lung cancer
2003
A phase II study of CPT-11, a new derivative of camptothecin, for previously untreated non-small-cell lung cancer.
1992
Phase I study of irinotecan and cisplatin with granulocyte colony-stimulating factor support for advanced non-small-cell lung cancer.
1994
A randomized trial in inoperable non-small-cell lung cancer: vindesine and cisplatin versus mitomycin, vindesine, and cisplatin versus etoposide and cisplatin alternating with vindesine and mitomycin.
1991
Phase I Study of Weekly Intravenous Infusions of CPT-11, a New Derivative of Camptothecin, in the Treatment of Advanced Non-Small-Cell Lung Cancer
1991
Phase II trial of carboplatin plus oral etoposide for elderly patients with small-cell lung cancer
1998
CPT-11 in combination with cisplatin for advanced non-small-cell lung cancer.
1992
CPT-11: a new derivative of camptothecin for the treatment of refractory or relapsed small-cell lung cancer.
1992
A phase II study of palonosetron combined with dexamethasone to prevent nausea and vomiting induced by highly emetogenic chemotherapy
2009
Effect of age on the responses of rat bladder detrusor strips to adenosine triphosphate
2000
Involvement of hydrogen peroxide production in erbstatin-induced apoptosis in human small cell lung carcinoma cells.
1996
In vitro transformation of chenodeoxycholic acid and ursodeoxycholic acid by human intestinal flora, with particular reference to the mutual conversion between the two bile acids.
1981
Isolation and characterization of thirteen intestinal microorganisms capable of 7 alpha-dehydroxylating bile acids
1981
p53 status and prognosis in stage I-IIIa non-small cell lung cancer
1997
Effect of dextranase on the extracellular polysaccharide synthesis of Streptococcus mutans; chemical and scanning electron microscopy studies
1975
Purification and characterization of surface fibrils from taxonomically typical Actinomyces viscosus WVU627
1981
Epimerization of the 7-hydroxy group of bile acids by the combination of two kinds of microorganisms with 7 alpha- and 7 beta-hydroxysteroid dehydrogenase activity, respectively.
1981
Prognostic significance of telomeric repeat length alterations in pathological stage I-IIIA non-small cell lung cancer.
2000
Transformation of bile acids by Eubacterium lentum
1981
Characterization of NADP-dependent 7 beta-hydroxysteroid dehydrogenases from Peptostreptococcus productus and Eubacterium aerofaciens
1982
Transformation of bile acids by Clostridium perfringens
1981
7 alpha-Dehydroxylation of bile acids by resting cells of an unidentified, gram-positive, nonsporeforming anaerobic bacterium
1983